P. V. Shirodaria

858 total citations
38 papers, 707 citations indexed

About

P. V. Shirodaria is a scholar working on Epidemiology, Genetics and Infectious Diseases. According to data from OpenAlex, P. V. Shirodaria has authored 38 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 10 papers in Genetics and 9 papers in Infectious Diseases. Recurrent topics in P. V. Shirodaria's work include Virology and Viral Diseases (10 papers), Virus-based gene therapy research (7 papers) and Animal Virus Infections Studies (7 papers). P. V. Shirodaria is often cited by papers focused on Virology and Viral Diseases (10 papers), Virus-based gene therapy research (7 papers) and Animal Virus Infections Studies (7 papers). P. V. Shirodaria collaborates with scholars based in United Kingdom, Ireland and Slovakia. P. V. Shirodaria's co-authors include K. B. Fraser, C. R. Pringle, Richard Matthews, C. F. Stanford, David Simpson, Ernest A. Gould, E. A. C. Follett, Margaret Haire, H. B. Gimenez and Stuart S. Levine and has published in prestigious journals such as The Lancet, Journal of Virology and Infection and Immunity.

In The Last Decade

P. V. Shirodaria

38 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. V. Shirodaria United Kingdom 16 446 192 117 97 89 38 707
Åke Espmark Sweden 17 266 0.6× 200 1.0× 80 0.7× 57 0.6× 85 1.0× 33 585
Donald R. Mayo United States 20 590 1.3× 308 1.6× 163 1.4× 139 1.4× 55 0.6× 52 1.0k
A. W. Gledhill Tanzania 17 358 0.8× 216 1.1× 100 0.9× 127 1.3× 57 0.6× 36 822
H K Andersen Denmark 23 915 2.1× 355 1.8× 330 2.8× 80 0.8× 347 3.9× 54 1.4k
K Saha India 14 204 0.5× 243 1.3× 162 1.4× 38 0.4× 34 0.4× 70 595
Mir A. Ali United States 16 448 1.0× 114 0.6× 259 2.2× 100 1.0× 182 2.0× 31 829
S Pincus United States 16 481 1.1× 321 1.7× 234 2.0× 191 2.0× 58 0.7× 23 1.1k
Vivi‐Anne Sundqvist Sweden 16 499 1.1× 175 0.9× 161 1.4× 38 0.4× 85 1.0× 25 713
Kuei-Hsiang Lin Taiwan 16 273 0.6× 247 1.3× 125 1.1× 110 1.1× 46 0.5× 33 585
Robert G. Sherding United States 17 183 0.4× 116 0.6× 59 0.5× 140 1.4× 38 0.4× 43 1.0k

Countries citing papers authored by P. V. Shirodaria

Since Specialization
Citations

This map shows the geographic impact of P. V. Shirodaria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. V. Shirodaria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. V. Shirodaria more than expected).

Fields of papers citing papers by P. V. Shirodaria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. V. Shirodaria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. V. Shirodaria. The network helps show where P. V. Shirodaria may publish in the future.

Co-authorship network of co-authors of P. V. Shirodaria

This figure shows the co-authorship network connecting the top 25 collaborators of P. V. Shirodaria. A scholar is included among the top collaborators of P. V. Shirodaria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. V. Shirodaria. P. V. Shirodaria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Macnab, J. C. M., et al.. (1992). Patients with cervical cancer produce an antibody response to an HSV‐inducible tumour‐specific cell polypeptide. International Journal of Cancer. 50(4). 578–584. 2 indexed citations
2.
O'Neill, Hugh J. & P. V. Shirodaria. (1992). Virus-specific antibodies to Epstein-Barr virus, varicellazoster virus and rubella virus in renal transplant patients with cytomegalovirus infections. Journal of Infection. 24(3). 301–309. 4 indexed citations
3.
Shirodaria, P. V., et al.. (1992). Comparison of immunodiffusion and enzyme linked immunosorbent assay in the detection of abnormal antibodies in pigeon breeder's disease.. Journal of Clinical Pathology. 45(6). 490–493. 15 indexed citations
4.
Ellis, D. S., et al.. (1988). Morphology and development of Rift Valley fever virus in vero cell cultures. Journal of Medical Virology. 24(2). 161–174. 28 indexed citations
5.
O’Neill, H. J., et al.. (1988). Cytomegalovirus‐specific antibody responses in renal transplant patients with primary and recurrent CMV infections. Journal of Medical Virology. 24(4). 461–470. 16 indexed citations
6.
Steele, K, P. V. Shirodaria, Herbert Pfister, et al.. (1988). A study of HPV 1, 2 and 4 antibody prevalence in patients presenting for treatment with cutaneous warts to general practitioners in N. Ireland. Epidemiology and Infection. 101(3). 537–546. 4 indexed citations
7.
Steele, K, P. V. Shirodaria, Michael O’Hare, et al.. (1988). Monochloroacetic acid and 60% salicylic acid as a treatment for simple plantar warts: effectiveness and mode of action. British Journal of Dermatology. 118(4). 537–544. 42 indexed citations
8.
O’Neill, H. J., et al.. (1988). Low and high molecular weight cytomegalovirus‐specific immunoglobulin M antibody in renal transplant patients with cytomegalovirus infections. Journal of Medical Virology. 24(4). 445–451. 1 indexed citations
9.
Shirodaria, P. V.. (1987). Viral Antibody Titers. Archives of Neurology. 44(12). 1237–1237. 50 indexed citations
10.
Pringle, C. R., P. V. Shirodaria, H. B. Gimenez, & Stuart S. Levine. (1981). Antigen and Polypeptide Synthesis by Temperature-sensitive Mutants of Respiratory Syncytial Virus. Journal of General Virology. 54(1). 173–183. 37 indexed citations
11.
Shirodaria, P. V., et al.. (1979). Virus-specific and anticellular antibodies in molluscum contagiosum. British Journal of Dermatology. 101(2). 133–140. 10 indexed citations
12.
Shirodaria, P. V., et al.. (1979). Measles virus-specific antibodies and immunoglobulin M antiglobulin in sera from multiple sclerosis and rheumatoid arthritis patients. Infection and Immunity. 25(1). 408–416. 24 indexed citations
13.
Pringle, C. R., et al.. (1978). Initiation and maintenance of persistent infection by respiratory syncytial virus. Journal of Virology. 28(1). 199–211. 33 indexed citations
14.
Shirodaria, P. V., et al.. (1976). Incidence of virus-specific antibodies and autoantibodies in sera of patients with warts. Clinical and Experimental Dermatology. 1(3). 269–274. 7 indexed citations
15.
Shirodaria, P. V. & Richard Matthews. (1975). An immunofluorescence study of warts.. PubMed. 21(2). 329–38. 27 indexed citations
16.
Shirodaria, P. V., et al.. (1973). Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-IgM.. Annals of the Rheumatic Diseases. 32(1). 53–57. 108 indexed citations
17.
Fraser, K. B., Margaret Haire, P. V. Shirodaria, & John Millar. (1973). MULTIPLE SCLEROSIS AND VIRUS ANTIGENS. The Lancet. 302(7840). 1271–1271. 2 indexed citations
18.
Mawhinney, Helen & P. V. Shirodaria. (1973). Immunofluorescence as a method of detecting antibody to soluble and particulate antigens and its application to the demonstration of immunoglobulin class. Journal of Immunological Methods. 3(3). 243–249. 1 indexed citations
19.
Millar, John, et al.. (1971). Immunoglobulin M. Specific for Measles and Mumps in Multiple Sclerosis. BMJ. 2(5758). 378–380. 34 indexed citations
20.
Fraser, K. B., P. V. Shirodaria, & C. F. Stanford. (1971). Fluorescent staining and human IgM.. BMJ. 3(5776). 707.1–707. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Åke Espmark Breakdown of academic impact, for papers by Donald R. Mayo Breakdown of academic impact, for papers by A. W. Gledhill Breakdown of academic impact, for papers by H K Andersen Breakdown of academic impact, for papers by K Saha Breakdown of academic impact, for papers by Mir A. Ali Breakdown of academic impact, for papers by S Pincus Breakdown of academic impact, for papers by Vivi‐Anne Sundqvist Breakdown of academic impact, for papers by Kuei-Hsiang Lin Breakdown of academic impact, for papers by Robert G. Sherding
Rankless by CCL
2026